Biogen Financial Statements From 2010 to 2026

Biogen Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 30.9 B 29.4 B 20.7 B Slightly volatile Short and Long Term Debt Total 7.3 B 6.9 B 5 B Slightly volatile Other Current Liabilities 2.9 B 2.7 B 2.2 B Slightly volatile Total Current Liabilities 3.5 B 3.3 B 3 B Slightly volatile Total Stockholder Equity 19.2 B 18.3 B 11.6 B Slightly volatile Property Plant And Equipment Net 3.5 B 3.3 B 2.8 B Slightly volatile Cash 3.2 B 3 B 1.7 B Slightly volatile Non Current Assets Total 21.5 B 20.5 B 14.2 B Slightly volatile Non Currrent Assets Other 703.8 M 431.9 M 1.3 B Very volatile Cash And Short Term Investments 4 B 3.8 B 2.9 B Slightly volatile Net Receivables 2 B 1.9 B 1.7 B Slightly volatile Common Stock Shares Outstanding 139.4 M 146.7 M 205.4 M Slightly volatile Liabilities And Stockholders Equity 30.9 B 29.4 B 20.7 B Slightly volatile Non Current Liabilities Total 8.2 B 7.8 B 6.1 B Slightly volatile Other Current Assets 1.2 B 1.1 B 815.4 M Slightly volatile Total Liabilities 11.7 B 11.2 B 9.1 B Slightly volatile Property Plant And Equipment Gross 6.6 B 6.3 B 3.4 B Slightly volatile Total Current Assets 9.4 B 9 B 6.5 B Slightly volatile Intangible Assets 9.6 B 9.2 B 4.4 B Slightly volatile Accounts Payable 453.6 M 432 M 349.1 M Slightly volatile Common Stock Total Equity 85.5 K 90 K 118.7 K Slightly volatile Common Stock 85.5 K 90 K 118.7 K Slightly volatile Short Term Debt 76.4 M 80.4 M 405 M Slightly volatile Inventory 2.3 B 2.2 B 1.2 B Slightly volatile Other Liabilities 969.6 M 1.5 B 1.4 B Slightly volatile Other Assets 2 B 1.9 B 1.4 B Slightly volatile Long Term Debt 3.2 B 6.3 B 4.3 B Slightly volatile Property Plant Equipment 2.1 B 3.8 B 2.6 B Slightly volatile Good Will 3.5 B 6.5 B 4.1 B Slightly volatile Net Tangible Assets 4.1 B 6.7 B 4.2 B Slightly volatile Retained Earnings Total Equity 11.5 B 18.9 B 12.2 B Slightly volatile Long Term Debt Total 4.3 B 7.2 B 4.6 B Slightly volatile Capital Surpluse 62.7 M 66 M 1.4 B Slightly volatile Deferred Long Term Liabilities 631.7 M 384.9 M 560.3 M Pretty Stable Non Current Liabilities Other 1 B 748.5 M 976.1 M Slightly volatile Short and Long Term Debt 2.1 B 2 B 658.2 M Slightly volatile Net Invested Capital 20.6 B 24.5 B 18.8 B Pretty Stable Net Working Capital 4.5 B 5.6 B 4.3 B Pretty Stable Capital Stock 80 K 90 K 98.2 K Slightly volatile Deferred Long Term Asset Charges 3 B 3.7 B 2.7 B Slightly volatile Capital Lease Obligations 286.1 M 290.4 M 382.6 M Slightly volatile
Biogen Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 982.2 M 935.4 M 560.1 M Slightly volatile Selling General Administrative 2.6 B 2.4 B 2 B Slightly volatile Total Revenue 10.3 B 9.8 B 9.6 B Slightly volatile Gross Profit 4.1 B 6.9 B 7.8 B Slightly volatile Other Operating Expenses 8.3 B 7.9 B 6.3 B Slightly volatile Cost Of Revenue 3 B 2.9 B 1.7 B Slightly volatile Total Operating Expenses 5.3 B 5 B 4.6 B Slightly volatile Income Tax Expense 102.7 M 108.1 M 720.3 M Pretty Stable Research Development 1.5 B 2 B 2.2 B Slightly volatile Net Income Applicable To Common Shares 2 B 3.5 B 2.8 B Slightly volatile Net Income From Continuing Ops 1.2 B 1.3 B 2.5 B Very volatile Non Recurring 99.1 M 118 M 121.2 M Pretty Stable Selling And Marketing Expenses 66.6 M 60.1 M 77.5 M Very volatile Tax Provision 250.4 M 263.6 M 932.3 M Slightly volatile Interest Income 109.1 M 125 M 101.5 M Pretty Stable Reconciled Depreciation 536.6 M 779.9 M 831.8 M Slightly volatile
Biogen Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 2.5 B 2.4 B 1.5 B Slightly volatile Capital Expenditures 146.1 M 153.8 M 575.1 M Pretty Stable Net Income 1.3 B 1.3 B 2.5 B Very volatile End Period Cash Flow 3.2 B 3 B 1.7 B Slightly volatile Stock Based Compensation 206.2 M 290.8 M 179.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.5 2.6316 9.8802 Slightly volatile Dividend Yield 0.0028 0.0023 0.0021 Slightly volatile PTB Ratio 1.34 1.4141 5.0666 Slightly volatile Days Sales Outstanding 86.13 69.4611 65.205 Slightly volatile Book Value Per Share 131 124 66.6236 Slightly volatile Stock Based Compensation To Revenue 0.0251 0.0296 0.0189 Slightly volatile PB Ratio 1.34 1.4141 5.0666 Slightly volatile EV To Sales 2.88 3.0332 9.9851 Slightly volatile Inventory Turnover 1.76 1.3362 1.4702 Pretty Stable Days Of Inventory On Hand 260 273 277 Pretty Stable Payables Turnover 7.04 6.706 5.1151 Very volatile Sales General And Administrative To Revenue 0.16 0.2481 0.2067 Very volatile Research And Ddevelopement To Revenue 0.19 0.1992 0.25 Slightly volatile Capex To Revenue 0.0149 0.0157 0.0704 Slightly volatile Cash Per Share 27.31 26.0102 16.1956 Slightly volatile Interest Coverage 7.25 7.6321 36.9589 Slightly volatile Payout Ratio 0.74 0.46 0.4519 Very volatile Days Payables Outstanding 51.71 54.4287 81.7265 Slightly volatile Intangibles To Total Assets 0.56 0.5323 0.3785 Slightly volatile Current Ratio 2.55 2.6793 2.5649 Slightly volatile Tangible Book Value Per Share 18.52 17.636 16.0572 Pretty Stable Receivables Turnover 6.0 5.2547 5.8021 Slightly volatile Graham Number 165 157 133 Slightly volatile Shareholders Equity Per Share 131 124 66.6171 Slightly volatile Debt To Equity 0.19 0.3806 0.3837 Slightly volatile Capex Per Share 1.18 1.0484 2.7777 Pretty Stable Revenue Per Share 70.22 66.8753 53.6689 Slightly volatile Interest Debt Per Share 51.49 49.0389 30.511 Slightly volatile Debt To Assets 0.25 0.236 0.212 Slightly volatile Short Term Coverage Ratios 26.05 27.4204 318 Slightly volatile Operating Cycle 373 343 308 Slightly volatile Price Book Value Ratio 1.34 1.4141 5.0666 Slightly volatile Days Of Payables Outstanding 51.71 54.4287 81.7265 Slightly volatile Dividend Payout Ratio 0.74 0.46 0.4519 Very volatile Ebt Per Ebit 0.62 0.7465 0.8917 Slightly volatile Company Equity Multiplier 1.16 1.6125 1.7129 Slightly volatile Long Term Debt To Capitalization 0.28 0.2648 0.2472 Slightly volatile Total Debt To Capitalization 0.29 0.2757 0.265 Slightly volatile Debt Equity Ratio 0.19 0.3806 0.3837 Slightly volatile Quick Ratio 1.93 2.032 2.2014 Slightly volatile Net Income Per E B T 0.92 0.9229 0.8046 Slightly volatile Cash Ratio 1.76 0.8982 0.9982 Slightly volatile Cash Conversion Cycle 263 288 224 Slightly volatile Days Of Inventory Outstanding 260 273 277 Pretty Stable Days Of Sales Outstanding 86.13 69.4611 65.205 Slightly volatile Cash Flow Coverage Ratios 0.3 0.3173 1.1284 Slightly volatile Price To Book Ratio 1.34 1.4141 5.0666 Slightly volatile Fixed Asset Turnover 2.04 2.9543 3.3566 Pretty Stable Debt Ratio 0.25 0.236 0.212 Slightly volatile Cash Flow To Debt Ratio 0.3 0.3173 1.1284 Slightly volatile Price Sales Ratio 2.5 2.6316 9.8802 Slightly volatile Asset Turnover 0.33 0.3332 0.4686 Slightly volatile Gross Profit Margin 0.5 0.7047 0.8106 Slightly volatile Price Fair Value 1.34 1.4141 5.0666 Slightly volatile
Biogen Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 9.4 B 11.6 B 12 B Pretty Stable Enterprise Value 9.4 B 11.6 B 12 B Pretty Stable

Biogen Fundamental Market Drivers

Biogen Upcoming Events

About Biogen Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen Details

Is Biogen Stock a good investment? Details

What is Biogen's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details